vix.ing · top · new · best · stats · spec

Wiebke Wessels

  1. IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response
    2026/03/27 by Sonja Bendig, Alina Hartmann, Wiebke Wessels +25 · 1 voice
    Medicine · #Acute Lymphoblastic Leukemia research #Chronic Myeloid Leukemia Treatments #Lymphoma Diagnosis and Treatment